Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity

Journal of Controlled Release

Volumn 101, Issue 1-3 SPEC. ISS., 2005, Pages 93-109

  Ehrbar, Martin ^a   Metters, Andrew ^b   Zammaretti, Prisca ^a   Hubbell, Jeffrey A ^a,c   Zisch, Andreas H ^a,d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b CLEMSON UNIVERSITY   (United States)

^c Switzerland   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Controlled release; Endothelial progenitor cells; Fibrin; Graft endothelialization; Proteolysis; VEGF

Indexed keywords

CELL PROLIFERATION; COLLATERAL VESSELS; ENDOTHELIAL CELLS; MICROVESSELS;

COATINGS; INTEGRATION; MATRIX ALGEBRA; OPTIMIZATION; SENSITIVITY ANALYSIS; TISSUE;

CELLS;

ANGIOGENIC FACTOR; FIBRIN; PLASMIN; VASCULOTROPIN;

ANGIOGENESIS; CELL ACTIVITY; CELL MATURATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG COATING; DRUG RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMOBILIZATION; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVASCULARIZATION; STEM CELL; TISSUE REPAIR;

CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; FIBRIN; HUMANS; MATHEMATICS; MODELS, BIOLOGICAL; PLASMIN; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 10044253411     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.07.018     Document Type: Conference Paper

References (31)

1. A.W. Clowes Improving the interface between biomaterials and the blood. The gene therapy approach Circulation 93 7 1996 1319 1320
2. M.J. Wissink, R. Beernink, A.A. Poot, G.H. Engbers, T. Beugeling, and W.G. van Aken Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices J. Control. Release 64 1-3 2000 103 114
3. J.L. Gray, S.S. Kang, G.C. Zenni, D.U. Kim, P.I. Kim, and W.H. Burgess FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia J. Surg. Res. 57 5 1994 596 612
4. S.S. Kang, C. Gosselin, D. Ren, and H.P. Greisler Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions Surgery 118 2 1995 280 286 (discussion 286-7)
5. H.P. Greisler, D.J. Cziperle, D.U. Kim, J.D. Garfield, D. Petsikas, and P.M. Murchan Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment Surgery 112 2 1992 244 254 (discussion 254-5)
6. P.K. Shireman, and H.P. Greisler Fibrin sealant in vascular surgery: a review J. Long-Term Eff. Med. Implants 8 2 1998 117 132
7. P. Zilla, R. Fasol, P. Preiss, M. Kadletz, M. Deutsch, and H. Schima Use of fibrin glue as a substrate for in vitro endothelialization of PTFE vascular grafts Surgery 105 4 1989 515 522
8. C. Merzkirch, N. Davies, and P. Zilla Engineering of vascular ingrowth matrices: are protein domains an alternative to peptides? Anat. Rec. 263 4 2001 379 387
9. M. Deutsch, J. Meinhart, M. Vesely, T. Fischlein, P. Groscurth, and U. von Oppell In vitro endothelialization of expanded polytetrafluoroethylene grafts: a clinical case report after 41 months of implantation J. Vasc. Surg. 25 4 1997 757 763
10. D.A. Weatherford, J.E. Sackman, T.T. Reddick, M.B. Freeman, S.L. Stevens, and M.H. Goldman Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition Surgery 120 2 1996 433 439
11. P.K. Shireman, B. Hampton, W.H. Burgess, and H.P. Greisler Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions J. Vasc. Surg. 29 5 1999 852 861 (discussion 862)
12. M. Ehrbar, V.G. Djonov, C. Schnell, S.A. Tschanz, G. Martiny-Baron, and U. Schenk Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth Circ. Res. 94 8 2004 1124 1132
13. A.H. Zisch, M.P. Lutolf, and J.A. Hubbell Biopolymeric delivery matrices for angiogenic growth factors Cardiovasc. Pathol. 12 6 2003 295 310
14. S.E. Sakiyama-Elbert, A. Panitch, and J.A. Hubbell Development of growth factor fusion proteins for cell-triggered drug delivery FASEB J. 15 7 2001 1300 1302
15. A.H. Zisch, U. Schenk, J.C. Schense, S.E. Sakiyama-Elbert, and J.A. Hubbell Covalently conjugated VEGF-fibrin matrices for endothelialization J. Control. Release 72 1-3 2001 101 113
16. A.H. Zisch, M.P. Lutolf, M. Ehrbar, G.P. Raeber, S.C. Rizzi, and N. Davies Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth FASEB J. 17 15 2003 2260 2262
17. D. Seliktar, A.H. Zisch, M.P. Lutolf, J.L. Wrana, and J.A. Hubbell MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing J. Biomed. Mater. Res. 68A 4 2004 704 716
18. M.P. Lutolf, G.P. Raeber, A.H. Zisch, N. Tirelli, and J.A. Hubbell Cell-responsive synthetic hydrogels Adv. Mater. 15 2003 888 892
19. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, and T. Li Isolation of putative progenitor endothelial cells for angiogenesis Science 275 5302 1997 964 967
20. M.M. Stump, G.L. Jordan Jr., M.E. Debakey, and B. Halpert Endothelium grown from circulating blood on isolated intravascular dacron hub Am. J. Pathol. 43 1963 361 367
21. Q. Shi, S. Rafii, M.H. Wu, E.S. Wijelath, C. Yu, and A. Ishida Evidence for circulating bone marrow-derived endothelial cells Blood 92 2 1998 362 367
22. S. Rafii, and D. Lyden Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration Nat. Med. 9 6 2003 702 712
23. B. Assmus, V. Schachinger, C. Teupe, M. Britten, R. Lehmann, and N. Dobert Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI) Circulation 106 24 2002 3009 3017
24. T. Murohara Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors Trends Cardiovasc. Med. 11 8 2001 303 307
25. C. Kalka, H. Masuda, T. Takahashi, W.M. Kalka-Moll, M. Silver, and M. Kearney Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization Proc. Natl. Acad. Sci. U. S. A. 97 7 2000 3422 3427
26. S. Dimmeler, A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, and M. Tiemann HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway J. Clin. Invest. 108 3 2001 391 397
27. S. Kaushal, G.E. Amiel, K.J. Guleserian, O.M. Shapira, T. Perry, and F.W. Sutherland Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo Nat. Med. 7 9 2001 1035 1040
28. J.C. Schense, and J.A. Hubbell Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa Bioconjug. Chem. 10 1 1999 75 81
29. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 6 2003 669 676
30. M. Peichev, A.J. Naiyer, D. Pereira, Z. Zhu, W.J. Lane, and M. Williams Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors Blood 95 3 2000 952 958
31. S.E. Sakiyama-Elbert, and J.A. Hubbell Development of fibrin derivatives for controlled release of heparin-binding growth factors J. Control. Release 65 3 2000 389 402